Dr. Zhiping Guo | Taiyuan Central Hospital, Peking University First Hospital Taiyuan Branch | China
Dr. Zhiping Guo, an esteemed Associate Chief Physician and Department Head at the Department of Hematology, Peking University First Hospital Taiyuan Branch (Taiyuan Central Hospital), is widely recognized for his dedicated contributions to the field of hematology. Having completed his postdoctoral research at the Peking University Institute of Hematology under the mentorship of Professor Xiaojun Huang, Dr. Guo has focused extensively on the diagnosis and treatment of hematological diseases, with remarkable advancements in clinical research and therapeutic strategies. He has successfully led multiple grant-funded research projects supported by prestigious provincial and municipal foundations. Dr. Guo has published over twenty peer-reviewed scientific papers in reputed international journals indexed in SCI and Scopus, reflecting his strong research output. His scholarly influence is underscored by an impressive h-index of 12, with more than 480 citations and 28 documented research works available in leading academic databases. As a peer reviewer for several international journals such as Molecular Medicine Reports, International Journal of Molecular Medicine, Experimental and Therapeutic Medicine, World Academy of Sciences Journal, and Oncology Letters, Dr. Guo plays a vital role in advancing global hematology research. A committed member of the EBMT, he continues to integrate innovation, clinical excellence, and academic leadership in his pursuit of improving hematological healthcare.
Featured Publications
Zhao, L., Zhang, Y., Guo, X., Li, Z., Lu, W., Pan, Z., Guo, Y., Sun, J., Zhang, Y., Hao, J., et al. (2024). Peripheral blood lymphocyte subsets in factor VIII inhibitor-positive patients with severe hemophilia A: A case-control study. Clinical and Applied Thrombosis/Hemostasis, 30(1).
Guo, Z., Chen, X., Tan, Y., Xu, Z., & Xu, L. (2020). Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study. Blood Cells, Molecules, and Diseases, 81, 102393.
Guo, Z.-P., Tan, Y.-H., Li, J.-L., Xu, Z.-F., Chen, X.-H., & Xu, L.-R. (2018). Acute pro-B-cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review. Oncology Letters, 15(5), 6895–6901.
Zhu, H.-H., Guo, Z.-P., Jia, J.-S., Jiang, Q., Jiang, H., & Huang, X.-J. (2018). The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia. Leukemia Research, 66, 75–80.
Guo, Z., Yang, L., Qin, X., Liu, X., & Zhang, Y. (2018). Spectrum of molecular defects in 216 Chinese families with hemophilia A: Identification of noninversion mutation hot spots and 42 novel mutations. Clinical and Applied Thrombosis/Hemostasis, 24(1), 134–141.